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Abstract
Cell stress and infection promote the formation of ubiquitinated aggregates in both non-immune and immune cells. These
structures are recognised by the autophagy receptor p62/sequestosome 1 and are substrates for selective autophagy. The
intracellular growth of Salmonella enterica occurs in a membranous compartment, the Salmonella-containing vacuole (SCV),
and is dependent on effectors translocated to the host cytoplasm by the Salmonella pathogenicity island-2 (SPI-2) encoded
type III secretion system (T3SS). Here, we show that bacterial replication is accompanied by the formation of ubiquitinated
structures in infected cells. Analysis of bacterial strains carrying mutations in genes encoding SPI-2 T3SS effectors revealed
that in epithelial cells, formation of these ubiquitinated structures is dependent on SPI-2 T3SS effector translocation, but is
counteracted by the SPI-2 T3SS deubiquitinase SseL. In macrophages, both SPI-2 T3SS-dependent aggregates and
aggresome-like induced structures (ALIS) are deubiquitinated by SseL. In the absence of SseL activity, ubiquitinated
structures are recognized by the autophagy receptor p62, which recruits LC3 and targets them for autophagic degradation.
We found that SseL activity lowers autophagic flux and favours intracellular Salmonella replication. Our data therefore show
that there is a host selective autophagy response to intracellular Salmonella infection, which is counteracted by the
deubiquitinase SseL.
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Introduction
Salmonella enterica is a facultative intracellular pathogen that
survives and replicates in a variety of hosts. The virulence traits of
Salmonella include the Salmonella pathogenicity-island (SPI)-1- and -
2-encoded type 3 secretion systems (T3SSs), which are important
for invasion of host cells [1] and intracellular replication [2,3],
respectively. Intracellular replication occurs in a membrane-
enclosed compartment, the Salmonella-containing vacuole (SCV),
and requires the delivery of an extensive repertoire of effectors to
the host cytoplasm by the SPI-2 T3SS [4].
Ubiquitination is an essential process in eukaryotic cells that
regulates protein degradation, localization and function. The ability
to manipulate the ubiquitin system is a feature common to many
intracellular pathogens, including Salmonella, which delivers several
effectors to the cell cytosol that interfere with the host cell
ubiquitination [5,6]. Absence of the SPI-2 T3SS-delivered deubi-
quitinase SseL leads to an accumulation of ubiquitinated proteins
within infected cells and attenuates Salmonella virulence in mice [7].
Intracellular bacteria generate a diverse array of substrates that
are ubiquitinated during infection. These include vacuolar
membrane remnants produced after intracellular lysis of bacterial
vacuoles [8], bacterial cell wall products [9] and protein aggregates
or aggresome-like induced structures (ALIS) [10–12]. In addition,
bacterial LPS, cell stress and toll-like receptor (TLR) signalling can
trigger the formation of ALIS in several cell types, including
macrophages [13,14]. ALIS and other ubiquitinated protein
aggregates are targeted by ubiquitin binding proteins such as
p62/sequestosome 1 (p62 hereafter), which can lead to receptor-
mediated selective macroautophagy (hereafter referred to as
selective autophagy).
In response to this cellular defence pathway, bacteria have
evolved different ways to interfere with selective autophagy. Listeria
ActA recruits the Arp2/3 complex and Ena/VASP to the surface
of cytosolic bacteria to prevent recognition by ubiquitin and p62
[15]. Likewise, Shigella camouflages its surface through binding of
the T3SS effector protein IcsB to the bacterial surface protein
IcsA/VirG, thereby preventing the recognition of VirG by the
autophagy-related protein, Atg5 [16], and avoiding recruitment of
ubiquitin and p62 [17].
The ubiquitination and selective autophagy of cytosolic
Salmonella has been studied extensively by others [18–20]. In this
work, we demonstrate that Salmonella within vacuoles induces a
cellular response leading to the formation of SPI-2 T3SS-
dependent ubiquitinated aggregates and ALIS during infection.
We show that a SPI-2 T3SS effector, SseL, deubiquitinates these
aggregates and prevents the recruitment of the autophagy markers
p62 and LC3. SseL deubiquitinase activity leads to a reduction in
autophagic flux during infection and promotes intracellular
bacterial replication.
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Ubiquitinated structures accumulate near Salmonella-
containing vacuoles
In epithelial cells, replicating Salmonella form a cluster of SCVs
(referred to as a microcolony) close to the microtubule organizing
centre and Golgi apparatus [21]. Bacterial replication is accom-
panied by dramatic reorganization of late endosomal compart-
ments [22], and condensation of actin [23], microtubules [24] and
intermediate filament networks [25], in close proximity to SCVs.
These processes could perturb cellular homeostasis and cause cell
stress. Since cell stress often leads to the appearance of inclusions
containing ubiquitinated proteins [11,13] confocal microscopy was
used to analyse the localization of mono- and poly-ubiquitinated
proteins in relation to bacterial microcolonies in HeLa cells
infected with Salmonella enterica serovar Typhimurium (S. Typhi-
murium) strains.
At 10 h after invasion, in addition to characteristic labelling of
the nucleus, punctate ubiquitin labelling was observed close to
bacterial microcolonies in approximately 40% of cells infected
with wild-type bacteria (Fig. 1A and 1B). In contrast, less than
10% of cells infected with an ssaV null mutant (DssaV) strain
(lacking a functional SPI-2 T3SS) had such structures (Fig. 1A and
1B), even after infection for 14 h, when the numbers of
intracellular DssaV bacteria were similar to those of the wild-type
strain at 10 h (Fig. 1D). This suggested that translocation of SPI-2
T3SS effectors is required for the formation of the majority of
these ubiquitinated aggregates. Several SPI-2 T3SS effectors
directly interfere with ubiquitin pathways by acting as E3 ligases
(SspH1, SspH2 and SlrP) [26,27] or as a deubiquitinase (SseL) [6].
SCV-associated ubiquitinated aggregates in cells infected with
strains lacking the E3 ligases were similar to those in cells infected
with wild-type bacteria (Fig. 1B) and were also present following
infection with a triple mutant strain lacking all three E3 ligases
(Fig. S1). In contrast, 75% of cells infected with DsseL mutant
bacteria showed striking SCV-associated ubiquitin labelling
(Fig. 1A and 1B), indicating that the presence of SseL results in
the loss of ubiquitinated structures near SCVs. These results
suggest that SPI-2 T3SS effector translocation induces the
accumulation of aggregates close to SCVs that are ubiquitinated
by unknown E3 ligase(s) and are deubiquitinated by SseL.
SseL deubiquitinase activity inhibits the accumulation of
ubiquitinated aggregates
To establish that the deubiquitinase activity of SseL was
required to reduce the frequency of SCV-associated ubiquitinated
aggregates, HeLa cells were infected with a Salmonella DsseL mutant
strain complemented with plasmid-expressed epitope-tagged
versions of SseL: SseL or SseLC262A (SseLC/A), a mutant that
lacks a catalytic cysteine required for its activity [7]. Complemen-
tation with wild-type SseL dramatically reduced the frequency of
cells containing ubiquitinated structures, whereas translocated
SseLC/A had no noticeable effect, despite extensive co-localiza-
tion with ubiquitin (Fig. 1B and S2A). Ubiquitin structures within
clusters of at least five bacteria were detected from approximately
6 h after bacterial invasion, coinciding with the onset of SPI-2
T3SS effector translocation [28,29] (Fig. 1C); infections with
bacteria lacking SseL resulted in a consistent increase in their
frequency from 8 h onwards (Fig. 1C). Deletion of sseL had no
major effect on the number of ubiquitinated cytosolic bacteria
occurring at early time-points after invasion (Fig. S2C),
indicating that the accumulation of ubiquitin near SCVs is distinct
from the ubiquitination of the small proportion of cytosolic
Salmonella.
Endosomal remodelling is required for the accumulation
of ubiquitinated aggregates
Colocalization between SCV-associated ubiquitin labelling and
the lysosomal membrane glycoprotein LAMP1 (Fig. 1A) suggested
that manipulation of host vesicular trafficking pathways might be
involved in the accumulation of ubiquitin. Salmonella SPI-2 T3SS
effectors, including SifA, induce and regulate extensive tubular
networks called Salmonella-induced filaments (sifs) that are enriched
in late endosomal markers such as LAMP1 [30] and cause the
collapse of endosomal compartments around SCVs [31]. To
investigate whether there was a link between the accumulation of
the ubiquitinated aggregates and these effects we analysed HeLa
cells infected with additional S. Typhimurium mutant strains.
Deletion of sifA alone results in instability of the SCV
membrane and bacterial escape [32,33], therefore we analysed
HeLa cells infected with double mutant strains containing
mutations in either sifA and sseJ or sifA and sopD2, as these strains
have increased membrane stability [34,35]. Because the sifA, sseJ
double mutant strain has a reduced replication rate [36], cells were
examined 14 h after invasion, when it was possible to compare
cells with similar numbers of bacteria as cells infected with wild-
type bacteria at 10 h after invasion (Fig. 1D). At this time point
only 25% of the cells infected with sifA, sseJ double mutant strain
contained SCV-associated ubiquitinated aggregates (Fig. 1D).
However, cells infected with a sifA, sopD2 double mutant or sseJ
mutant strain contained the same frequency of ubiquitinated
structures observed with wild-type Salmonella (Fig. 1D).
Salmonella also induces extensive rearrangement of actin and
microtubules around SCVs [23,24]. To determine whether these
processes are required for the formation of ubiquitinated
aggregates, HeLa cells were infected with single mutant strains
lacking SseG, which is required for formation of bundles of
microtubules [37] or SteC, which causes assembly of an SCV-
associated F-actin meshwork [38]. Both these strains induced
ubiquitinated aggregates to similar levels as seen in cells infected
with wild-type bacteria (data not shown). Hence, accumulation of
these aggregates is not linked to positioning of SCVs or actin
polymerization, but is at least in part due to the combined actions
of SifA and SseJ.
Author Summary
Ubiquitination can target substrates to a number of fates,
including autophagy, the essential cellular process that
allows cells to degrade cytosolic material. Although
Salmonella enterica resides in a vacuolar compartment
during infection, it translocates several virulence proteins
into the host cell cytoplasm. We have found that
intracellular Salmonella induces the formation of ubiquiti-
nated aggregates near the Salmonella-containing vacuole
and that these aggregates are recognised by the autoph-
agy machinery. Salmonella inhibits this response through
the action of a translocated enzyme, SseL, which
deubiquitinates the aggregates and thereby decreases
the recruitment of autophagy markers. We show that SseL
alone can deubiquitinate known substrates that are
degraded by autophagy, that it reduces autophagy in
infected cells and that its activity can increase intracellular
Salmonella replication. This is a new example of how a
bacterium counteracts a cellular defence pathway through
the action of a translocated virulence protein.
Deubiquitination of Autophagy Substrates by SseL
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forms K63-linked chains
The ultrastructure of these ubiquitinated aggregates was
examined by transmission immunoelectron microscopy (IEM).
Ubiquitin labelling was observed in electron-dense structures in
both wild-type and DsseL infected cells (Fig. 2A). In agreement
with our observations by confocal microscopy, ubiquitin labelling
was found more frequently in DsseL than wild-type infected cells
and was found in very close proximity to SCVs. No labelling was
found within the luminal space or on bacteria by IEM. Further
Figure 1. Ubiquitinated aggregates accumulate near SCVs in HeLa cells. (A) Single confocal sections of HeLa cells infected with GFP-
expressing S. Typhimurium strains (blue) for 10 h, fixed and immunolabelled for LAMP1 (green) and ubiquitin (Ub, red) (false coloured, scale bars,
5 mm). The far right panels show merged images of LAMP1, ubiquitin and Salmonella. Arrows indicate SCV-associated ubiquitinated aggregates. (B)
Quantification of the percentage of infected cells containing SCV-associated ubiquitinated aggregates. Cells were processed as in (A) and analysedb y
fluorescence microscopy. (C) Kinetics of the formation of SCV-associated ubiquitinated aggregates. Cells were infected with GFP-expressing S.
Typhimurium strains for the indicated amount of time, and processed as in (A). (D) Quantification of the percentage of infected cells with SCV-
associated ubiquitinated aggregates in HeLa cells infected with S. Typhimurium strains for 14 h. Cells were processed as in (A) and analysed by
fluorescence microscopy. For all quantifications, a minimum of 50 infected cells were counted per experiment and values are the mean 6 SEM from
at least 3 independent experiments. * p,0.05; ** p,0.01; *** p,0.001.
doi:10.1371/journal.ppat.1002743.g001
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recognizing either lysine 48-linked (K48) or lysine 63-linked (K63)
ubiquitin chains revealed that K63 but not K48 ubiquitin chains
were present in these structures (Fig. 2B), consistent with the
known preference of SseL for K63 chains [7]. However, co-
localization between the FK2 antibody (which labels all ubiquitin
chains) and the K63 antibody was incomplete; therefore it is
possible that other ubiquitin topologies might also be present.
p62 and LC3 localize to SCV-associated ubiquitinated
aggregates
Autophagy is required for the clearance of various types of
ubiquitinated aggregates induced following bacterial infection
[39]. This clearance can involve p62, which interacts with both
ubiquitin chains and LC3 to promote the autophagic degradation
of protein inclusions [40].
We analysed the distribution of p62 and LC3 in HeLa cells
infected with wild-type or DsseL mutant bacteria. Dense punctate
labelling of both p62 and LC3 was detected close to SCVs, and
this partly co-localized with ubiquitin (Fig. 3A and 3B). To
examine the influence of SseL on these proteins, confocal
microscopy was used to measure the relative fluorescence intensity
of ubiquitin, p62 and LC3 labelling in SCV-associated structures.
The absence of SseL significantly increased the intensity of
ubiquitin, p62 and LC3 labelling, compared to cells infected with
wild-type bacteria (Fig. 3C–E). This was complemented by a
plasmid expressing wild-type SseL, but not by expression of
SseLC/A (Fig. 3C–E).
The presence of ubiquitin and p62 within the same aggregates
was confirmed by IEM analysis of infected HeLa cells, which
showed dense structures in the vicinity of SCVs co-labelled with
p62 and ubiquitin (Fig. S3A). Likewise, a HeLa cell line stably
expressing GFP-LC3 also contained ubiquitin and GFP-LC3
positive structures close to SCVs (Fig. S3B). Together, these results
demonstrate that the deubiquitinase activity of SseL reduces the
presence of ubiquitin, p62 and LC3 in SCV-associated aggregates.
SCV-associated aggregates are regulated by autophagy
To examine the role of autophagy in the regulation of these
structures, HeLa cells infected with DsseL mutant bacteria were
subjected to conditions that either inhibit or stimulate autophagy
and examined for the presence of SCV-associated ubiquitinated
aggregates (Fig. 4). 3-methyladenine (3-MA), ammonium chloride
(NH4Cl) or bafilomycin A1 (BafA1) were used to inhibit autophagy
at early (3-MA) and late (NH4Cl and BafA1) stages of the pathway;
starvation and rapamycin were used to stimulate autophagy. To
avoid any interference with the maturation of the SCV and early
targeting of cytosolic bacteria, infected cells were maintained in
normal medium until 8 h after invasion. Cells were then exposed
to autophagy-altering conditions for 4 h before processing for
confocal microscopy. The frequency of ubiquitinated aggregates
was enhanced significantly upon inhibition of autophagosome
formation (3-MA) or autophagic degradation (BafA1 and NH4Cl),
whereas stimulation of autophagy by starvation or rapamycin
strongly reduced their presence (Fig. 4A and 4B). The alterations
in autophagic flux were confirmed by an increased presence of
Figure 2. Ubiquitin accumulates in dense cytosolic aggregates and forms K63-linked chains. (A) Immunoelectron microscopy of HeLa
cells infected with S. Typhimurium strains for 12 h (ubiquitin - 10 nm gold particles; scale bars, 0.5 mm). Arrows indicate ubiquitin accumulations near
bacteria within vacuoles. (B) Single confocal sections of HeLa cells infected with GFP-expressing DsseL mutant bacteria (blue) for 10 h and
immunolabelled for ubiquitin (all chain types - Ub, red) and lysine-48-linked (K48-Ub, green) or lysine-63-linked (K63-Ub, green) ubiquitin chains (false
coloured, scale bars, 5 mm). Arrows indicate SCV-associated ubiquitin and K63-Ub labelling.
doi:10.1371/journal.ppat.1002743.g002
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LC3-positive compartments were almost undetectable in cells
exposed to 3-MA despite the increase in ubiquitin labelling
(Fig. 4B). BafA1, which inhibits degradation of lysosomal contents,
enhanced both ubiquitin and LC3 labelling of these compartments
(Fig. 4B). These results show that the ubiquitinated aggregates
induced by SPI-2 T3SS effectors are substrates of the autophagy
pathway.
SseL deubiquitinates ALIS
Stimulation of macrophages and dendritic cells with LPS
induces the formation of cytosolic ubiquitinated aggregates that
are subject to autophagy. These are referred to as aggresome-like
induced structures (ALIS) [11,13,40]. We showed previously that
lysates from mouse macrophages infected with DsseL mutant
bacteria are enriched in ubiquitinated proteins [7]. Immunoflu-
orescence and IEM analysis of infected RAW264.7 macrophages
revealed the presence of small ubiquitin puncta similar to those
seen in epithelial cells, as well as larger, more spherical aggregates
that were particularly evident in cells infected with the DsseL
mutant strain (Fig. 5). In RAW264.7 macrophages, these larger
structures were up to approximately 0.5 mm in diameter, similar to
the size of ALIS [14] (Fig. 5C), and they co-labelled with p62
(Fig. 5C and 5D) and LC3 (Fig. 5E). Fluorescence microscopy
revealed that HA-tagged SseLC/A co-localized to approximately
50% of ALIS in infected RAW264.7 macrophages (data not
shown) and the effector was also visualised on cytosolic structures
co-labelled with ubiquitin by IEM (Fig. S2B).
As there was a continuum of different sized puncta in
RAW264.7 macrophages, the percentage of infected cells with
any ubiquitin-positive aggregates was quantified. Approximately
35% of macrophages infected with the wild-type strain contained
ALIS and other aggregates 10 h after bacterial uptake (Fig. 5A
and 5B). 24% of cells infected with DssaV mutant strain also
contained these structures, indicating that the majority of
aggregates in macrophages are induced independently of SPI-2
T3SS function. Indeed, a similar proportion of uninfected cells
that had been exposed to bacteria contained ubiquitinated
aggregates (Fig. 5B). Since it is known that E. coli and S.
Typhimurium LPS induce ALIS in macrophages [13,14], LPS is
likely to account for the SPI-2-independent induction of
ubiquitinated aggregates.
Approximately 70% of RAW264.7 macrophages infected with
DsseL mutant bacteria contained ubiquitinated aggregates (Fig. 5B).
SseL-dependent deubiquitination of aggregates was also observed
in infected mouse bone marrow-derived primary macrophages
(Fig. S4). These cells contained large ALIS that were readily
distinguishable from SCV-associated aggregates. Their quantita-
tion revealed that wild-type Salmonella-infected cells had fewer
ALIS than uninfected cells in the same well, whereas cells infected
with DsseL mutant bacteria had a far greater number (Fig. 6A).
Uninfected cells not exposed to extracellular bacteria did not
contain any ALIS (Fig. S5).
Figure 3. SseL DUB activity reduces the recruitment of ubiquitin and autophagic markers to Salmonella microcolonies. Single confocal
sections of HeLa cells infected with GFP-expressing DsseL mutant bacteria (blue) for 12 h and immunolabelled for ubiquitin (Ub, red) and (A) p62
(green) or (B) LC3 (green) (false coloured, scale bars, 5 mm). The far right panels show merged images of p62 or LC3, ubiquitin and Salmonella. Arrows
indicate SCV-associated ubiquitin labelling with p62 or LC3. (C–E). Quantification of the relative fluorescence intensity of (C) ubiquitin, (D) p62 and (E)
LC3 per microcolony (see Materials and Methods). Cells were processed as in (A) and a minimum of 30 microcolonies analysed for each bacterial
infection per experiment. Results from representative experiments showing the relative mean fluorescence intensity 6 SEM are shown. Similar results
were obtained in at least 3 independent experiments. * p,0.05; ** p,0.01; *** p,0.001.
doi:10.1371/journal.ppat.1002743.g003
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independently-generated ALIS, we transiently transfected HeLa
cells with vectors encoding myc-tagged SseL or myc-tagged
SseLC/A. LPS does not induce ALIS in HeLa cells, but
puromycin (which causes premature chain termination during
translation) leads to the accumulation of defective ribosomal
products (DRiPs) that are ubiquitinated and incorporated into
inclusion bodies. These aggregates also contain p62 and are
indistinguishable from LPS-induced ALIS [11,14,40]. HeLa cells
were either mock transfected or transfected with a vector
expressing myc-tagged SseL or SseLC/A, then treated with
puromycin for 4 h and analysed for ALIS. There were approx-
imately 5-fold fewer ALIS in cells expressing SseL compared to
mock-transfected or SseLC/A-expressing cells (Fig. 6B and 6C).
Collectively, these experiments show that SseL is sufficient to
deubiquitinate proteins in Salmonella- or puromycin-induced ALIS.
SseL interacts with p62 and autophagic substrates
The catalytically inactive SseL mutant (SseLC/A) binds stably
to ubiquitinated substrates and allows their immunoprecipitation
[7]. To determine if SseL can co-immunoprecipitate autophagic
substrates, macrophages were infected with the sseL deletion
mutant expressing either wild-type SseL-HA or SseLC/A-HA
from a plasmid, and after 10 h of infection, lysates were
immunoprecipitated with an anti-HA antibody (Fig. 7A). Immu-
noblotting revealed that p62 was specifically co-immunoprecipi-
tated by SseLC/A-HA (Fig. 7A). A similar result was obtained
using infected HeLa cells (data not shown). This shows that SseL
and p62 might bind to the same ubiquitinated substrates.
Furthermore, since p62 was immunoprecipitated by SseLC/A
but not wild-type SseL (Fig. 7A), it is likely that this interaction
occurs indirectly through the ubiquitinated substrates. Next we
examined the effects of autophagy on the accumulation of SseL-
interacting ubiquitinated substrates. Infected macrophages were
subjected to 3 h of 3-MA or starvation treatment to inhibit or
stimulate autophagic flux respectively before cell lysis. 3-MA
markedly increased the levels of ubiquitinated proteins interacting
with SseLC/A (Fig. 7B). In contrast, starvation conditions virtually
eliminated these substrates (Fig. 7B). Therefore, SseL deubiquiti-
nates substrates targeted by p62 and destined for autophagic
degradation.
SseL reduces autophagic flux and influences bacterial
replication in macrophages
Accumulation of protein aggregates has been shown to induce
autophagy in models of Huntington’s disease [41]. In addition,
LPS-induced ALIS formation increases autophagic flux in
macrophages [11,42]. Since SseL deubiquitinates ALIS, we
analysed autophagic flux by determining LC3-II levels in infected
Figure 4. SCV-associated ubiquitinated aggregates are autophagy substrates. (A) Quantification of the percentage of infected cells with
SCV-associated ubiquitinated aggregates. HeLa cells were infected with DsseL mutant bacteria for 12 h. At 8 h post-infection, cells were subjected to
the indicated treatments for 4 h before fixation and immunolabelling. A minimum of 50 cells were counted per condition in each experiment and
values are the mean 6 SEM of at least 3 independent experiments. p values are relative to the mean value of mock-treated cells. * p,0.05; ** p,0.01;
*** p,0.001. (B) Single confocal sections of HeLa cells infected with GFP-expressing DsseL mutant bacteria (blue), treated and processed as in (A) and
analysed by fluorescence microscopy for ubiquitin (Ub, red) and LC3 (green) (scale bars, 5 mm). The far right panels show merged images of LC3,
ubiquitin and Salmonella.
doi:10.1371/journal.ppat.1002743.g004
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RAW264.7 macrophages infected with GFP-expressing strains of S. Typhimurium (green) for 10 h and immunolabelled for ubiquitin (Ub, red) (scale
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nolamine (LC3-II) it localizes to autophagosomal membranes [43]
and the amount of LC3-II correlates with the number of
autophagosomes present in cells. Exposure of cells to NH4Cl to
inhibit lysosomal degradation allows differentiation between an
increase in autophagic flux and impaired autophagic degradation
[43,44]. Cells infected with sseL mutant bacteria had increased
levels of LC3-II compared to wild-type infected cells and this was
complemented when bacteria expressed wild-type SseL but not
SseLC/A (Fig. 8A and B). Following exposure to NH4Cl, the levels
of LC3-II were still higher in the absence of SseL (Fig. 8A and B),
indicating that the increase in LC3-II observed in cells infected
bars, 5 mm). (B) Quantification of infected macrophages containing ubiquitinated aggregates 10 h after bacterial uptake. Cells were processed as in
(A) and analysed by fluorescence microscopy. A minimum of 50 cells were counted for each bacterial infection per experiment and values are the
mean 6 SEM of at least 3 independent experiments. * p,0.05; *** p,0.001. Uninfected cells (uninf) were from the same wells as infected and
therefore were exposed to extracellular bacteria. (C) Immunoelectron microscopy of RAW264.7 macrophages infected with the DsseL mutant bacteria
for 12 h. Arrows and arrowheads indicate ubiquitin (15 nm gold particles) and p62 (10 nm gold particles), respectively (scale bar, 0.5 mm). (D and E)
Single confocal sections of RAW264.7 macrophages infected with GFP-expressing strains of S. Typhimurium (blue) and immunolabelled for ubiquitin
(Ub, red) and (D) p62 (green) or (E) LC3 (green). The far right panels show merged images of p62 or LC3, ubiquitin and Salmonella. Arrows indicate
Arrows indicate SCV-associated ubiquitin labelling with p62 or LC3 (scale bars, 5 mm). Cell outlines and nuclei are delineated by white lines.
doi:10.1371/journal.ppat.1002743.g005
Figure 6. SseL deubiquitinates Salmonella- and puromycin-induced ALIS. (A) Quantification of large (.2 mm), ubiquitinated aggresome-like
induced structures (ALIS) in macrophages. Primary bone marrow-derived macrophages (BMM) were infected with the indicated GFP-expressing S.
Typhimurium strains for 10 h, immunolabelled for ubiquitin and analysed by confocal microscopy. A minimum of 50 cells were counted for each
bacterial infection per experiment and values are the mean 6 SEM of 3 independent experiments. Uninfected cells (uninf) were from the same wells
as infected and therefore were exposed to extracellular bacteria. * p,0.05; ** p,0.01. (B) Quantification of the number of puromycin-induced
ubiquitin inclusions in cells. HeLa cells were transfected with a vector expressing myc-SseL or myc-SseLC/A for 16 h followed by treatment with
puromycin (5 mg/ml) for 4 h and immunolabelled with anti-myc, anti-p62 and anti-ubiquitin. 50 individual cells were counted per condition in each
experiment. Values are the means 6 SEM of at least 3 independent experiments. ** p,0.01. (C) Single confocal sections of HeLa cells transfected with
a vector expressing myc-SseL for 16 h followed by treatment with puromycin (5 mg/ml) for 4 h and immunolabelled with anti-myc (blue), anti-p62
(green) and anti-ubiquitin (Ub, red) (scale bars, 5 mm). The lower panels show a merged image of p62, ubiquitin and myc-SseL. Arrows indicate
ubiquitin and p62 aggregates present in untransfected cells and arrowheads indicate cells expressing myc-SseL.
doi:10.1371/journal.ppat.1002743.g006
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autophagosomal degradation. Therefore, the absence of SseL
deubiquitinase activity stimulates autophagic flux, presumably by
increasing the accumulation of ubiquitinated aggregates.
Previous studies have demonstrated that SseL contributes to the
virulence of S. Typhimurium in mice, but failed to show an
intracellular growth defect of sseL mutant strains [7,45]. In view of
its effect on ALIS, we reassessed the contribution of SseL to
intracellular bacterial replication using fluorescence dilution, a
technique which enables direct measurement of bacterial replica-
tion at the single cell level [3]. The replication of wild-type and
DsseL mutant bacteria was indistinguishable 10 h after uptake into
RAW264.7 cells (Fig. 8C). The mean replication of both strains
was approximately 40-fold at 10 h, as calculated by fluorescence
dilution [3]. However, DsseL mutant bacteria complemented with
a plasmid overexpressing SseL underwent a ,35% increase in
bacterial replication. This increase was not observed for isogenic
bacteria expressing the catalytically inactive SseLC/A (Fig. 8C).
RAW264.7 cells are relatively permissive for replication of S.
Typhimurium [3]. To examine the replication in a more
physiological and restrictive environment, primary macrophages
were also used to compare replication of the sseL mutant (Fig. 8D).
Mouse bone marrow-derived macrophages were infected for 16 h
and bacterial replication was determined by fluorescence dilution.
The replication of sseL mutant Salmonella at 16 h (10.5-fold) was
significantly lower than that of wild-type bacteria (17-fold)
(Fig. 8D), indicating that SseL contributes to replication in this
more restrictive cellular environment.
Discussion
We have shown that intravacuolar Salmonella induces the
formation of ubiquitinated aggregates containing autophagic
markers in both epithelial cells and macrophages. In epithelial
cells, rather diffuse ubiquitin puncta were found close to SCVs,
and these partially co-localized with LAMP1 and electron-dense
material. These structures were SPI-2 T3SS-dependent and
required the combined activities of SifA and SseJ, effectors that
regulate vacuolar membrane dynamics and which perturb the
endosomal network [35]. Infected macrophages contained similar
structures and also dense, more spherical aggregates that resemble
ALIS. Although such ALIS have not been characterized
previously in Salmonella-infected cells, they are similar to those
induced in macrophages following bacterial LPS stimulation
[13,14]. The aggregates found in Salmonella-infected macrophages
resembled LPS-induced ALIS in their size, shape and recruitment
of p62 and LC3 [14], suggesting that LPS signalling through
TLR4 might trigger their formation. Remarkably, both aggregates
and ALIS in epithelial cells and macrophages are targets for the
SPI-2 T3SS effector, SseL, which deubiquitinates as yet uniden-
tified p62-bound proteins and reduces the recruitment of
autophagic machinery.
It was reported recently that knockout of the deubiquitinase
AMSH (associated molecule with the SH3 domain of STAM) in
mice caused accumulation of ubiquitinated inclusions containing
p62 in neurons [46]. In addition, LPS-induced autophagic
signalling can be reduced by the deubiquitinase A20 which
deubiquitinates K63-linked chains from Beclin-1 [47]. However, it
is not known whether A20 or AMSH act directly on substrates of
autophagy or whether their effects are indirect. Therefore, to our
knowledge SseL is the first deubiquitinase to be described that
targets material destined for autophagic degradation, and this
represents a new mechanism by which Salmonella counteracts a
cellular response induced by an innate immune signalling
pathway. It is likely that a proportion of the ubiquitinated
aggregates found in macrophages form in response to LPS-TLR4
signalling, as S. Typhimurium LPS stimulates ALIS formation in
RAW 264.7 macrophages [13] and LPS-induced ALIS in
macrophages have been shown to require TLR4 signalling [14].
However other bacterial products may also be involved; Listeria
monocytogenes culture broth, zymosan beads as well as heat
treatment and cell stress have been shown to induce ALIS
formation in several cell types [11,13]. The presence of
ubiquitinated aggregates in Salmonella-infected macrophages might
also be inhibited by other effectors that interfere with TLR-
dependent immune signalling, such as the phosphothreonine lyase
SpvC, which acts on MAP kinases downstream of MyD88 [48].
Figure 7. SseL interacts with p62 and autophagic substrates. (A and B) Co-immunoprecipitation from RAW264.7 macrophages infected with
DsseL mutant bacteria expressing SseL-HA or SseLC/A-HA for 10 h. (A) Infectedcell lysates and immunoprecipated fractions were probed with anti-
HA, anti-ubiquitin and anti-p62 antibodies. (B) At 7 h post-infection, infected cells were subjected to mock, 3-MA or starvation (Stv) treatments for3h
before harvesting and processing as described in (A). Cell lysates and immunoprecipiations were probed with anti-HA and anti-ubiquitin antibodies.
doi:10.1371/journal.ppat.1002743.g007
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agy have been described in cells exposed to other bacterial
pathogens, but these have mainly been cytosolic or extracellular
bacteria [8,9,49,50]. However, expression of the Legionella
pneumophila Dot/Icm type IV secretion system in macrophages
was shown to reduce ALIS formation during infection [12].
Although a Legionella deubiquitinase has not yet been identified,
these observations together with our results suggest that such an
activity might exist. Indeed it is possible that deubiquitinases of
other pathogens might target ubiquitinated aggregates in a similar
way, and their activity could mask the presence of these
aggregates.
An inability to degrade misfolded or aggregated proteins can
lead to cell death, as seen in neurodegenerative disorders [51].
Autophagy ameliorates the cellular stress induced by the presence
of protein aggregates [52]. Therefore it is possible that the
reduction in autophagic flux mediated by SseL accounts for its
ability to induce delayed cytotoxicity in macrophages [7]. While
the possible functions of ALIS remain unclear, they serve to
sequester cytosolic proteins under a variety of stress conditions and
are suggested to be involved in host immune defence [14,53,54].
The ubiquitinated proteins in ALIS are considered as a source of
antigenic peptides for presentation on MHC class I molecules in
dendritic cells [14,53,54]; therefore the deubiquitination of
aggregates by SseL might regulate antigen presentation in infected
macrophages. It will be important to determine the fate of proteins
contained within Salmonella-induced aggregates following deubi-
quitination by SseL. As ubiquitin, p62 and LC3 are currently the
only markers of these structures, we are unable to assess whether
they persist in cells following their deubiquitination. The presence
of non-ubiquitinated protein inclusions may also adversely affect
the cell and impede bacterial replication. The identity of the
substrates within aggregates that are targeted for deubiquitination
by SseL remains elusive. The ability of exogenously expressed
SseL to target puromycin-induced ALIS suggests that it may be a
promiscuous deubiquitinase that can target a number of substrates
and that its activity is regulated by its localization to the SCV
during infection.
It is known that the activity of SseL contributes to Salmonella
growth in vivo [7]. In the present study we found that SseL also
contributes to intracellular replication in macrophages. In the
permissive RAW264.7 macrophage cell line, no differences in
replication were observed between wild-type bacteria and the
DsseL mutant, but an increase in replication occurred upon over-
expression of active SseL. However, in the more restrictive bone-
marrow derived macrophages, which better represent the cells that
Salmonella encounters in vivo, replication was reduced in the absence
of SseL.
Figure 8. SseL reduces autophagic flux and can promote bacterial replication in macrophages. (A) Lipidated LC3B (LC3-II) levels in
RAW264.7 macrophages infected with the indicated strains of S. Typhimurium for 12 h. Cells were left untreated (2) or subjected to 10 mM NH4Cl
treatment (+) for 2 h before harvesting. (B) Quantification of relative LC3 II levels in infected cells. Denistometry of bands was analysed using Image J
software. The ratio of LC3-II/tubulin signal intensity was normalized to 1 for wild-type untreated infections. The graph shows the mean relative LC3 II/
tubulin ratios 6 SEM for 3 independent experiments. (C) RAW264.7 or (D) murine bone marrow-derived primary macrophages were infected with the
indicated strains of S. Typhimurium for (C) 10 h or (D) 16 h and bacterial replication was monitored using flow cytometry. Results are represented as
fold replication normalized to wt; values are the means 6 SEM of at least 3 independent experiments. * p,0.05; ** p,0.01.
doi:10.1371/journal.ppat.1002743.g008
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protein (OSBP) [55], and interferes with lipid metabolism, leading
to the clearance of lipid droplets, which otherwise accumulate
during infection of mice gallbladder epithelial cells [56]. Lipid
droplet metabolism has been associated with autophagy [57];
therefore it would be interesting to study the possible relationship
between the inhibition of selective autophagy by SseL and its
interference with lipid droplet metabolism. Understanding how
SseL interferes with selective autophagy and contributes to
bacterial replication and cytotoxicity will be helped by the
identification of molecules present in the ubiquitinated aggregates
and the ubiquitin-conjugated proteins that are targeted by SseL.
Many intracellular bacteria produce effectors that are known to
interfere with ubiquitin-related processes, suggesting that modu-
lating this pathway is important for bacterial growth and survival
inside cells. During and following cell invasion, the ubiquitination
machinery is used by Salmonella SPI-1 T3SS effectors to regulate
both their degradation and cellular localization [58,59]. Our work
has shown that ubiquitinated aggregates are formed at late time-
points in infected cells, in response to both SPI-2 T3SS-dependent
rearrangement of endocytic compartments and to SPI-2 T3SS-
independent signals. We found that Salmonella uses the SPI-2 T3SS
effector SseL to deubiquitinate proteins in these aggregates,
thereby impeding their autophagic degradation. The possible links
between this interference of autophagy and SseL-associated
cytotoxicity and replication will be the subject of future research.
Materials and Methods
Bacterial strains, plasmids and culture conditions
Standard microbial techniques were used for construction of
strains and plasmids. Detailed information on the S. Typhimurium
strains and plasmids used in this study are provided in Tables S1
and S2 respectively [60,61]. Strains harbouring the pDiGc
plasmid were cultured in MgM-MES minimal medium supple-
mented with 0.2% L-arabinose at 37uC with aeration [3]. All other
strains were grown in Luria Bertani (LB) medium, at 37uC with
aeration. When appropriate, cultures were supplemented with
kanamycin (50 mg/ml) and carbenicillin (50 mg/ml). The chromo-
somal deletions of avrA, sspH1 and sspH2 in S. Typhimurium were
performed by one-step gene-disruption method [62]. sspH2 and
slrP mutations were transduced into DsspH1 and DsspH1DsspH2
mutant strains of S. Typhimurium respectively by P22 phage
transduction.
Cell culture and DNA transfection
HeLa (cloneHtA1) and RAW264.7 cells were obtained from the
European Collection of Animal and Cell Cultures, Salisbury, UK.
Cells were grown in Dulbecco’s modified Eagle medium (PAA
laboratories) supplemented with 10% foetal calf serum (PAA
laboratories) at 37uCi n5 % CO2. Primary bone marrow-derived
murine macrophages (BMM) were obtained from C57BL/6 mice
(Charles River) extracted from tibia and femur [63] and grown as
described [3]. HeLa cells were transfected using Lipofectamine
2000 (Invitrogen) transfection reagent according to the manufac-
turer’s instructions.
Bacterial infections
HeLa and RAW264.7 macrophage infections were performed
as previously described [32] except for infections carried out with
strains harbouring pDiGc, which were grown overnight in MgM-
MES supplemented with 0.2% L-arabinose [3]. Primary BMM
were infected as described [3]. For all experiments, coverslips from
1 h post-inoculation were labelled to verify that there were similar
levels of infection between strains and conditions. In BMM,
approximately 50% of cells were infected.
Antibodies
For confocal microscopy, FK2 mouse anti-mono and poly-
ubiquitinated proteins (ENZO) was used at 1:10,000; CSA-1 goat
anti-Salmonella (Kirkegaard and Perry Laboratories) at 1:400; 931A
rabbit anti-LAMP1 [64] at 1:1000; Clone Apu3 rabbit anti-K63
ubiquitin chains (Millipore) at 1:1000; Clone Apu2 rabbit anti-
K48 ubiquitin chains (Millipore) at 1:1000; rabbit anti-p62
(ENZO) at 1:1000; rabbit anti-LC3B (MBL) at 1:1000; 3H603
rat anti-myc (Santa Cruz) at 1:200; rat anti-HA (Roche) at 1:200.
Secondary antibodies were obtained from Invitrogen: Alexa 488-,
Alexa 555- and Alexa 633-conjugated donkey anti-goat, anti-
rabbit, anti-mouse, or anti-rat antibodies were used for immuno-
fluorescence at a dilution of 1:400. For immunoblotting, antibodies
were used at following dilutions: P4D1 mouse anti-ubiquitinated
proteins (Santa Cruz) 1:1000; HA11 mouse anti-HA (Covance)
1:5000; rabbit anti-actin (Sigma) 1:5000; rabbit anti-p62 at 1:1000
(MBL); anti-mouse (IgG) and anti-rabbit (IgG) horseradish
peroxidase secondary antibodies (GE Healthcare) at 1:10,000.
For immunoelectron microscopy the following antibodies and
reagents were used: rabbit anti-GFP (Rockland) at 1:100; mouse
anti-rabbit (Dako) at 1:300; rabbit anti-p62 (ENZO) at 1:30; and
Protein A gold from the Cell Microscopy Center, UMC Utrecht,
The Netherlands.
Reagents and drug treatments
All drugs were prepared in stock solutions and stored as
indicated by the manufacturer. 3-Methyladenine (3-MA) (Sigma)
was used at 10 mM [65]; bafilomycin A1 (BafA1) (Sigma) at
200 nM [40]; rapamycin (Sigma) at 0.2 mg/ml [66]; puromycin
(Sigma) at 5 mg/ml [40]. For starvation treatments cells were
incubated in Hank’s buffer salt solution (HBSS). NH4Cl was used
at 10 mM.
Confocal immunofluorescence microscopy
For confocal microscopy, samples were fixed in 4% formalde-
hyde and permeabilized in 0.2% Triton X-100 for 5 min. All
antibodies were diluted to the appropriate concentration in PBS
containing 10% horse serum. The coverslips were washed twice in
PBS, incubated with primary antibodies for 1 h, washed 3 times in
PBS and incubated with secondary antibodies for 30 min.
Coverslips were washed and mounted onto glass slides using
Mowiol mounting medium. Cells were observed with a confocal
laser scanning microscope (Zeiss Axiovert LSM510) or an
epifluorescence microscope (BX50 Olympus Optical). Images
were processed using Zeiss LSM510 image software and Adobe
Photoshop software. In all figures apart from S2A, single confocal
sections are shown. In Fig. S2A a projection of stacked confocal
sections is shown.
Puromycin-induced inclusion assays
HeLa cells were transfected with 500 ng of pRK5::myc-SseL
[67], pRK5::myc-SseLC/A or empty pRK5 for 16 h and cells
were subjected to puromycin treatment for additional 4 h until
processing for confocal microscopy. The number of ubiquitin
inclusions per cell was quantified for at least 50 cells for each
sample.
Immunofluorescence quantifications
To quantify the percentage of cells displaying ubiquitinated
structures around bacterial microcolonies (a cluster of at least five
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RAW264.7 macrophages or BMM were infected with strains of
S. Typhimurium and immunolabelled for mono and poly-
ubiquitinated proteins. Detection of the bacteria was done by
using GFP-expressing strains of S. Typhimurium [68] or by
immunolabelling with anti-Salmonella antibodies. Cells were scored
positive if the bacterial fluorescence signal overlapped ubiquitin
labelling. At least 50 infected cells were counted for each sample in
at least three independent experiments. Only cells containing a
minimum of five bacteria and a maximum of 20 bacteria were
counted. For quantification of the numbers of ubiquitinated
bacteria, at least 100 bacterial cells were counted for each sample
and analysed for pixel to pixel colocalization between ubiquitin
and GFP-expressing bacteria. The percentage of cells containing
at least one singular ubiquitinated bacterium was obtained by
counting 50 infected cells for each sample for each time-point. All
quantifications were done in a blind manner for at least 3
independent experiments.
Quantitative analysis of confocal projections
For the quantification of ubiquitin, p62 or LC3 on bacterial
microcolonies, HeLa cells were infected with strains S. Typhimur-
ium immunolabelled for mono and polyubiquitinated proteins,
p62, LC3 and Salmonella. 3D confocal stacks were acquired for
each sample using a slice increment of 0.4 mm. These stacks were
then analysed as 3D images using the Volocity software. A
protocol in the Volocity software was created and identical settings
used for analysis of all experiments. Intracellular bacteria were
selected according to an arbitrary threshold of fluorescence
intensity of anti-Salmonella labelling for all images. Manual
manipulation ensured that only cells with at least 5 bacteria
clustered in a perinuclear position were selected. All intracellular
bacteria were then grouped as one individual object containing the
volume of cellular cytoplasm. The mean values of fluorescence
intensity of ubiquitin, p62 or LC3 labelling present within
individual microcolonies were quantified and divided by the mean
values of fluorescence intensity of bacterial labelling. Data were
expressed as the ratio of mean fluorescence of ubiquitin, p62 or
LC3 to the fluorescence of bacteria. At least 30 individual
microcolonies were quantified for each sample per individual
experiment in a minimum of 3 independent experiments
(minimum of 90 microcolonies in total).
Immunoelectron microscopy (IEM)
For IEM of HeLa cells or RAW264.7 macrophages, cells were
infected with different strains of S. Typhimurium for 12 h, then
fixed, immunolabelled and embedded as previously described [9].
Single labeling to reveal FK2 antibody and sequential double
labeling were performed according to the protein A gold method
[69].
Immunoblot analysis of LC3B
For immunoblot analysis of the levels of LC3B, RAW264.7
macrophages (2610
6 cells) infected with strains of S. Typhimurium
were left untreated or incubated with 10 mM NH4Cl for 2 h
before harvesting. To ensure equivalent bacterial loads, coverslips
were examined at 1 h post-uptake and for all experiments,
approximately 70% of RAW264.7 macrophages were infected by
all strains. 12 h after bacterial uptake cells were washed and
harvested in ice cold PBS and centrifuged at 14,0006g for 2 min.
Cells were lysed in TBS (20 mM Tris-Cl, pH 7.5 150 mM NaCl)
containing 1% Triton X-100, 2.5 mM MgCl2, 1 mM PMSF and
16protease inhibitor cocktail (Roche) and lysates were centrifuged
at 14,0006g at 4uC for 10 min. Supernatants were resuspended in
sample buffer (0.25 mM Tris-Cl pH 6.8, 10% SDS, 50% glycerol,
5% b-mercaptoethanol) and subjected to SDS-PAGE followed by
immunoblot analysis. Immunoblots were developed using HRP-
conjugated secondary antibodies and visualised using ECL (GE
healthcare). Densitometry was performed on film by high-
resolution scanning and analysis using ImageJ software (NIH).
Co-immunoprecipitations
For HA immunoprecipitations, RAW264.7 macrophages
(6610
6 cells) infected with strains of S. Typhimurium for 12 h
were washed, harvested in cold PBS and centrifuged at 2006g at
4uC. Cells were lysed in RIPA buffer (Sigma) containing 1 mM
PMSF and 16protease inhibitor cocktail (Roche) and left on ice
for 30 min. The lysates were centrifuged at 14,0006g for 10 min
and the supernatants were pre-cleared with protein G-immobi-
lized beads (Pierce). After a brief centrifugation supernatants were
incubated overnight at 4uC with 30 ml of protein G-immobilized
beads conjugated to 1 mg of HA11 mouse anti-HA antibody
overnight at 4uC. Samples were then centrifuged for 30 sec at
14,0006g, and washed twice in lysis buffer. Immunoprecipitated
proteins were eluted from beads in sample buffer and subjected to
SDS-PAGE followed by immunoblot analysis.
Replication assays
Infections were carried out with strains harbouring pDiGc as
described. Briefly, bacteria were grown overnight in MgM-MES
supplemented with 0.2% L-arabinose prior to infection. At
appropriate time points after infection, intracellular bacteria
released from macrophages were analysed by flow cytometry on
a two-laser, four colour FACS Calibur
TM flow cytometer. Data
were analysed with FlowJo software version 8.1.1 (TreeStar). Fold
replication values from 2 h to the indicated time points were
calculated and normalised to wt. Results represent the means 6
SEM of at least 3 independent experiments.
Statistical analysis
All statistical analyses were performed with Prism 5 software
(GraphPad) using one-wayANOVA with Dunnett post hoc analyses to
compare different means in relation to a control sample, with
Newman-Keuls post hoc analyses for pairwise comparisons of more
than 2 different means or using two-tailed un-paired Student’s t-
test for comparison of means between 2 samples. For p
values,0.05, the differences between samples were considered
as statistically significant. In all figures, * p,0.05; ** p,0.01;
*** p,0.001.
Supporting Information
Figure S1 Formation of SCV-associated ubiquitinated
aggregates is independent of the SPI-2 T3SS-delivered
E3 ubiquitin ligases. (A) Single confocal sections of HeLa cells
infected with the indicated strains of S. Typhimurium for 10 h and
immunolabelled for ubiquitin (Ub, red) and Salmonella (green). The
far right panels show merged images of ubiquitin and Salmonella.
Cell outlines and nuclei are delineated by white lines (scale bars,
5 mm). Arrows indicate SCV-associated ubiquitin accumulations.
(TIF)
Figure S2 SseL deubiquitinates SCV-associated ubiqui-
tinated aggregates and ALIS but does not affect ubiqui-
tination of cytosolic bacteria. (A) Projection of stacked
confocal sections of HeLa cells infected with the indicated strains
of S. Typhimurium for 10 h and immunolabelled for ubiquitin
(Ub, red), HA (green) and Salmonella (blue). (B) Immunoelectron
Deubiquitination of Autophagy Substrates by SseL
PLoS Pathogens | www.plospathogens.org 12 June 2012 | Volume 8 | Issue 6 | e1002743microscopy of RAW264.7 macrophages infected with DsseL
mutant bacteria expressing SseLC/A-HA. Arrow indicates
ubiquitin - 15 nm gold particles; arrowhead indicates HA –
10 nm gold particles (scale bar, 0.5 mm). (C) Quantification of the
percentage of intracellular bacteria that are ubiquitinated over a
time-course of infection. Immunofluorescence quantification of
HeLa cells infected with GFP-expressing S. Typhimurium strains
for the indicated times, fixed and immunolabelled for ubiquitin.
100 bacterial cells were counted for each strain at each time-point.
All values are the means 6 SEM of 3 independent experiments.
(TIF)
Figure S3 Electron dense SCV-associated ubiquitinated
aggregates contain p62 and GFP-LC3 in infected HeLa
cells. (A) Immunoelectron microscopy of HeLa cells infected with
DsseL mutant bacteria for 12 h (arrowheads indicate ubiquitin -
15 nm gold particles; arrows indicate p62 – 10 nm gold particles;
scale bar, 0.5 mm). (B) Immunoelectron microscopy of HeLa cells
stably expressing GFP-LC3 infected with DsseL mutant bacteria
for 12 h (arrowheads indicate ubiquitin - 15 nm gold particles;
arrows indicate GFP-LC3 – 10 nm gold particles; scale bar,
0.5 mm).
(TIF)
Figure S4 SseL inhibits accumulation of SCV-associated
ubiquitinated aggregates in infected primary macro-
phages. (A) Representative single confocal sections of primary
bone marrow-derived macrophages (BMM) infected with GFP-
expressing strains of S. Typhimurium (green) for 16 h and
immunolabelled for ubiquitin (Ub, red). Arrows indicate ubiquitin
aggregates. Cell outlines and nuclei are delineated by white lines
(scale bars, 5 mm). (B) Immunoblot analysis of ubiquitinated
proteins from lysates of BMM infected with the indicated strains of
S. Typhimurium for 16 h or 20 h using anti-ubiquitin and anti-
actin antibodies. (C) Quantification of SCV-associated ubiquiti-
nated aggregates at 16 h after bacterial uptake in BMM. Cells
were processed as in (A) and analysed by fluorescence microscopy.
A minimum of 50 cells were counted for each sample and values
are the mean 6 SEM of at least 4 experiments independent
experiments. ** p,0.01.
(TIF)
Figure S5 Confocal images of ubiquitin levels in
primary macrophages. (A) Representative single confocal
sections of murine primary bone marrow-derived macrophages
infected with the indicated strains of GFP-expressing Salmonella
(green) for 10 h or uninfected (and unexposed to bacterial
products). Cells were fixed and labelled for ubiquitin (Ub, red)
and analysed by confocal microscopy (scale bars, 20 mm).
(TIF)
Table S1 Bacterial strains used in this work.
(DOCX)
Table S2 Plasmids used in this work.
(DOCX)
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